Related references
Note: Only part of the references are listed.Cardiovascular disease risk in antiphospholipid syndrome: Thrombo-inflammation and atherothrombosis
Maria G. Tektonidou
JOURNAL OF AUTOIMMUNITY (2022)
Solid Phase Assays for Antiphospholipid Antibodies
Katrien M. J. Devreese
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2022)
Epidemiology of Antiphospholipid Syndrome in the General Population
Jesse Y. Dabit et al.
CURRENT RHEUMATOLOGY REPORTS (2021)
Cholesterol efflux capacity and its association with prevalent metabolic syndrome in a multi-ethnic population (Dallas Heart Study)
Oludamilola Akinmolayemi et al.
PLOS ONE (2021)
New-onset IgG autoantibodies in hospitalized patients with COVID-19
Sarah Esther Chang et al.
NATURE COMMUNICATIONS (2021)
The intersection of COVID-19 and autoimmunity
Jason S. Knight et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Sex Differences in Systemic Lupus Erythematosus: Epidemiology, Clinical Considerations, and Disease Pathogenesis
Julie S. Nusbaum et al.
MAYO CLINIC PROCEEDINGS (2020)
Population-based estimates of humoral autoimmunity from the US National Health and Nutrition Examination Surveys, 1960-2014
Charles F. Dillon et al.
PLOS ONE (2020)
Antiphospholipid syndrome: a clinical perspective
Yu Zuo et al.
CHINESE MEDICAL JOURNAL (2020)
Is There an Additional Value in Detecting Anticardiolipin and Anti-β2 glycoprotein I IgA Antibodies in the Antiphospholipid Syndrome?
Walid Chayoua et al.
THROMBOSIS AND HAEMOSTASIS (2020)
NETs in APS: Current Knowledge and Future Perspectives
Ajay Tambralli et al.
CURRENT RHEUMATOLOGY REPORTS (2020)
Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19
Yu Zuo et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Prevalence and associations of anti-phosphatidylserine/prothrombin antibodies with clinical phenotypes in patients with primary antiphospholipid syndrome aPS/PT antibodies in primary antiphospholipid syndrome
Carlos A. Nunez-Alvarez et al.
THROMBOSIS RESEARCH (2019)
IgG Anti-high-Density Lipoproteins Antibodies Discriminate Between Arterial and Venous Events in Thrombotic Antiphospholipid Syndrome Patients
Savino Sciascia et al.
FRONTIERS IN MEDICINE (2019)
New Insights in the Pathophysiology of Antiphospholipid Syndrome
Anastasia Sacharidou et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2018)
The Contribution of Autoantibodies to Inflammatory Cardiovascular Pathology
Lee A. Meier et al.
FRONTIERS IN IMMUNOLOGY (2018)
Multimodality Strategy for Cardiovascular Risk Assessment Performance in 2 Population-Based Cohorts
James A. de Lemos et al.
CIRCULATION (2017)
Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis
Michael A. Gimbrone et al.
CIRCULATION RESEARCH (2016)
Antinuclear Antibodies Are Associated With All-Cause Mortality and Cardiovascular Outcomes in the General Population
Elizabeth Blair Solow et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Release of Neutrophil Extracellular Traps by Neutrophils Stimulated With Antiphospholipid Antibodies: A Newly Identified Mechanism of Thrombosis in the Antiphospholipid Syndrome
Srilakshmi Yalavarthi et al.
ARTHRITIS & RHEUMATOLOGY (2015)
The estimated frequency of antiphospholipid antibodies in young adults with cerebrovascular events: a systematic review
Savino Sciascia et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients
R. Cervera et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends
Maria Laura Bertolaccini et al.
AUTOIMMUNITY REVIEWS (2014)
Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome
Savino Sciascia et al.
THROMBOSIS AND HAEMOSTASIS (2014)
Neutrophil Extracellular Trap-Derived Enzymes Oxidize High-Density Lipoprotein An Additional Proatherogenic Mechanism in Systemic Lupus Erythematosus
Carolyne K. Smith et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus
Michelle Petri et al.
ARTHRITIS AND RHEUMATISM (2012)
Evaluation of Cardiovascular Risk in Patients With Rheumatoid Arthritis: Do Cardiovascular Biomarkers Offer Added Predictive Ability Over Established Clinical Risk Scores?
Axel Finckh et al.
ARTHRITIS CARE & RESEARCH (2012)
A sensitive assay for ABCA1-mediated cholesterol efflux using BODIPY-cholesterol
Sandhya Sankaranarayanan et al.
JOURNAL OF LIPID RESEARCH (2011)
The United States to Africa lupus prevalence gradient revisited
G. S. Gilkeson et al.
LUPUS (2011)
Risk factors for ANA positivity in healthy persons
Quan-Zhen Li et al.
ARTHRITIS RESEARCH & THERAPY (2011)
IgA Anti-β2-Glycoprotein I Autoantibodies Are Associated with an Increased Risk of Thromboembolic Events in Patients with Systemic Lupus Erythematosus
Nadera J. Sweiss et al.
PLOS ONE (2010)
Netting neutrophils in autoimmune small-vessel vasculitis
Kai Kessenbrock et al.
NATURE MEDICINE (2009)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Ethnic and geographical variation in antiphospholipid (Hughes) syndrome
I Uthman et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
The Dallas Heart Study: A population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health
RG Victor et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
β2-glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction -: The Honolulu Heart Program
RL Brey et al.
STROKE (2001)
Epidemiology of the antiphospholipid antibody syndrome
M Petri
JOURNAL OF AUTOIMMUNITY (2000)